Filed: 10/3/2023ACC: 0000950123-23-008652
📋 What this filing means
VIDA VENTURES ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $64.60M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$64.60M
Total AUM (reported)
16.90M
Total Shares
Allocation by class
COMMON STOCK$35.77M55.4%
ORDINARY SHARES$28.84M44.6%
Portfolio Concentration
Top 3$51.03M79.0%
4–10$13.57M21.0%
Top 3 weight
79.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 16.90M
Sole
Full voting authority
16.90M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings8
Rows:
Centessa Pharmaceuticals plc
SOLEShares3.93M
TypeSH
Market value$25.44M
39.38%
Sole
3.93M
Shared
0.00
None
0.00
Dyne Therapeutics, Inc.
SOLEShares2.22M
TypeSH
Market value$19.89M
30.79%
Sole
2.22M
Shared
0.00
None
0.00
Allogene Therapeutics, Inc.
SOLEShares1.80M
TypeSH
Market value$5.70M
8.82%
Sole
1.80M
Shared
0.00
None
0.00
Kronos Bio, Inc.
SOLEShares2.77M
TypeSH
Market value$3.59M
5.56%
Sole
2.77M
Shared
0.00
None
0.00
LianBio
SOLEShares2.28M
TypeSH
Market value$3.40M
5.26%
Sole
2.28M
Shared
0.00
None
0.00
Kinnate Biopharma, Inc.
SOLEShares2.21M
TypeSH
Market value$3.09M
4.78%
Sole
2.21M
Shared
0.00
None
0.00
Praxis Precision Medicines, Inc.
SOLEShares1.47M
TypeSH
Market value$2.51M
3.89%
Sole
1.47M
Shared
0.00
None
0.00
Ikena Oncology, Inc.
SOLEShares225.19K
TypeSH
Market value$975.1K
1.51%
Sole
225.19K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Centessa Pharmaceuticals plcSOLE | Ordinary Shares | 3.93M | SH | $25.44M 39.38% | 3.93M | 0.00 | 0.00 |
Dyne Therapeutics, Inc.SOLE | Common Stock | 2.22M | SH | $19.89M 30.79% | 2.22M | 0.00 | 0.00 |
Allogene Therapeutics, Inc.SOLE | Common Stock | 1.80M | SH | $5.70M 8.82% | 1.80M | 0.00 | 0.00 |
Kronos Bio, Inc.SOLE | Common Stock | 2.77M | SH | $3.59M 5.56% | 2.77M | 0.00 | 0.00 |
LianBioSOLE | Ordinary Shares | 2.28M | SH | $3.40M 5.26% | 2.28M | 0.00 | 0.00 |
Kinnate Biopharma, Inc.SOLE | Common Stock | 2.21M | SH | $3.09M 4.78% | 2.21M | 0.00 | 0.00 |
Praxis Precision Medicines, Inc.SOLE | Common Stock | 1.47M | SH | $2.51M 3.89% | 1.47M | 0.00 | 0.00 |
Ikena Oncology, Inc.SOLE | Common Stock | 225.19K | SH | $975.1K 1.51% | 225.19K | 0.00 | 0.00 |